These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 18401847

  • 1. Dermal and transcutaneous delivery of the major glycoside constituents of Harpagophytum procumbens (Devil's Claw) in vitro.
    Abdelouahab N, Heard CM.
    Planta Med; 2008 Apr; 74(5):527-31. PubMed ID: 18401847
    [Abstract] [Full Text] [Related]

  • 2. A novel ex vivo skin model for the assessment of the potential transcutaneous anti-inflammatory effect of topically applied Harpagophytum procumbens extract.
    Ouitas NA, Heard CM.
    Int J Pharm; 2009 Jul 06; 376(1-2):63-8. PubMed ID: 19383533
    [Abstract] [Full Text] [Related]

  • 3. Devil's Claw-a review of the ethnobotany, phytochemistry and biological activity of Harpagophytum procumbens.
    Mncwangi N, Chen W, Vermaak I, Viljoen AM, Gericke N.
    J Ethnopharmacol; 2012 Oct 11; 143(3):755-71. PubMed ID: 22940241
    [Abstract] [Full Text] [Related]

  • 4. Effect of the major glycosides of Harpagophytum procumbens (Devil's Claw) on epidermal cyclooxygenase-2 (COX-2) in vitro.
    Abdelouahab N, Heard C.
    J Nat Prod; 2008 May 11; 71(5):746-9. PubMed ID: 18412394
    [Abstract] [Full Text] [Related]

  • 5. Iridoid glycosides from Harpagophytum procumbens D.C. (devil's claw).
    Qi J, Chen JJ, Cheng ZH, Zhou JH, Yu BY, Qiu SX.
    Phytochemistry; 2006 Jul 11; 67(13):1372-7. PubMed ID: 16857222
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Identification of major and minor constituents of Harpagophytum procumbens (Devil's claw) using HPLC-SPE-NMR and HPLC-ESIMS/APCIMS.
    Clarkson C, Staerk D, Hansen SH, Smith PJ, Jaroszewski JW.
    J Nat Prod; 2006 Sep 11; 69(9):1280-8. PubMed ID: 16989520
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. New and known iridoid- and phenylethanoid glycosides from Harpagophytum procumbens and their in vitro inhibition of human leukocyte elastase.
    Boje K, Lechtenberg M, Nahrstedt A.
    Planta Med; 2003 Sep 11; 69(9):820-5. PubMed ID: 14598207
    [Abstract] [Full Text] [Related]

  • 18. [Therapy of degenerative diseases of the musculoskeletal system with South African devil's claw (Harpagophytum procumbens DC)].
    Wegener T.
    Wien Med Wochenschr; 1999 Sep 11; 149(8-10):254-7. PubMed ID: 10483693
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Ethosomes for skin delivery of ammonium glycyrrhizinate: in vitro percutaneous permeation through human skin and in vivo anti-inflammatory activity on human volunteers.
    Paolino D, Lucania G, Mardente D, Alhaique F, Fresta M.
    J Control Release; 2005 Aug 18; 106(1-2):99-110. PubMed ID: 15935505
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.